{"id":25561,"date":"2023-09-07T10:53:45","date_gmt":"2023-09-07T14:53:45","guid":{"rendered":"https:\/\/cdtrp.ca\/en\/?post_type=spucpt&p=25561"},"modified":"2023-09-07T10:53:45","modified_gmt":"2023-09-07T14:53:45","slug":"caroline-lamarche","status":"publish","type":"spucpt","link":"https:\/\/cdtrp.ca\/en\/spucpt\/caroline-lamarche\/","title":{"rendered":"Caroline Lamarche"},"content":{"rendered":"

Caroline Lamarche’s bio<\/strong><\/p>\n

D\"\"r Caroline Lamarche is a clinician scientist and transplant nephrologist at Maisonneuve-Rosemont Hospital. She is an assistant clinical professor at the Universit\u00e9 de Montr\u00e9al. After her nephrology training at the Universit\u00e9 de Montr\u00e9al (2015), she completed a Master degree on the use of adoptive immunotherapy to treat\/prevent BK nephropathy in kidney transplant recipients. She then pursued a post-doctoral fellowship with Dr. Megan Levings at the University of British Columbia on the use of chimeric antigen receptor (CAR) regulatory T cells (Tregs) to induce transplant tolerance. Her lab is working on the development of adoptive immunotherapy in nephrology and understanding Treg dysfunction.<\/p>\n","protected":false},"author":6,"template":"","class_list":["post-25561","spucpt","type-spucpt","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/spucpt\/25561"}],"collection":[{"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/spucpt"}],"about":[{"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/types\/spucpt"}],"author":[{"embeddable":true,"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/users\/6"}],"wp:attachment":[{"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/media?parent=25561"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}